ochratoxin a has been researched along with bromodeoxyuridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumbach, K; Dekant, W; Draheim, R; Hard, GC; Lutz, WK; Mally, A; Ozden, S; Rached, E; Steger, U; Weber, K | 1 |
| Ahr, HJ; Dietrich, DR; Ellinger-Ziegelbauer, H; Stemmer, K | 1 |
2 other study(ies) available for ochratoxin a and bromodeoxyuridine
| Article | Year |
|---|---|
Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats.
Topics: Administration, Oral; Animals; Antimetabolites; Blood Cell Count; Body Weight; Bromodeoxyuridine; Carcinogens; Cell Proliferation; Kidney; Liver; Male; Ochratoxins; Organ Size; Rats; Rats, Inbred F344; Tissue Distribution | 2007 |
Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors.
Topics: Animals; Apoptosis; Aristolochic Acids; Bromodeoxyuridine; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Kidney Neoplasms; Kidney Tubules; Models, Biological; Ochratoxins; Precancerous Conditions; Rats; Staining and Labeling; Trans-Activators; Transcription Factors | 2009 |